- Home
- IVT vs CLDX Comparison
IVT vs CLDX Comparison
Compare IVT & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVT | CLDX |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2005 | 1995 |
Fundamental Metrics
Financial Performance| Metric | IVT | CLDX |
|---|---|---|
| Price | $35.38 | $38.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $32.50 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 1.5M | 1.3M |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | ★ 647.37 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $299,169,000.00 | $12,743,000.00 |
| Revenue This Year | $8.42 | $111.39 |
| Revenue Next Year | $5.25 | $235.85 |
| P/E Ratio | $507.00 | ★ N/A |
| Revenue Growth | 9.20 | ★ 87.78 |
| 52 Week Low | $26.65 | $19.72 |
| 52 Week High | $36.27 | $40.30 |
Technical Indicators
Market Signals| Indicator | IVT | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 58.88 | 69.68 |
| Support Level | $33.84 | $28.51 |
| Resistance Level | $36.15 | N/A |
| Average True Range (ATR) | 0.64 | 1.75 |
| MACD | -0.07 | 0.61 |
| Stochastic Oscillator | 67.90 | 83.33 |
Price Performance
Historical ComparisonAbout IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.